Improving access to lung cancer screening through patient navigation
Official title: Health Education Approach to Lung Screening (HEALS)
Run by Virginia Commonwealth University · NCT06070870 · Data updated 2026-11-12
This study tests a patient navigation program to help more people, especially Black or African-American individuals with a certain smoking history, get screened for lung cancer using low dose CT scans.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 675 (estimated) |
| Sponsor | Virginia Commonwealth University Academic / other |
| Locations | 3 sites (Carrboro, North Carolina and 2 other locations) |
| Status | Recruiting |
| Started | October 10, 2023 |
| Main results expected | November 30, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | August 25, 2026 |
| Trial ID | NCT06070870 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Black or African-American individuals with a significant smoking history who meet the current guidelines for lung cancer screening.
✕Probably not a fit
Patients with a known history of cancer (except for certain skin cancers) or those who have experienced specific health issues in the past five years may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates a patient navigation program aimed at increasing the number of individuals who complete lung cancer screening using low dose computed tomography (LDCT). It is a single-arm intervention that focuses on guiding eligible patients through the screening process to enhance access and completion rates. The program targets individuals who meet specific smoking history and demographic criteria, particularly those identifying as Black or African-American. The effectiveness of this approach will be assessed by measuring the proportion of patients who undergo the screening after receiving navigation support.
Why it matters
Potential benefit: If successful, this program could significantly increase lung cancer screening rates among high-risk populations, leading to earlier detection and improved outcomes.
How similar studies have gone: Other studies have shown that patient navigation can effectively improve screening rates in various populations, suggesting a promising approach for this intervention.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Meets current USPSTF guidelines for lung cancer screening (LCS) * 20 pack-year smoking history Note: A pack-year is a way of calculating how much a person has smoked in their lifetime. One pack-year is the equivalent of smoking an average of 20 cigarettes-1 pack-per day for a year. * Currently smokes or has quit smoking within the past 15 years * Identifies as Black or African-American Note: Both Hispanic/Latino and Non-Hispanic/Latino patients are eligible as long as they also identify as Black or African-American (eg, Afro-Latino). * Willing to complete all navigation-related study activities * Able to understand and the willingness to sign a written informed consent document Exclusion Criteria: A patient who meets any of the following exclusion criteria is ineligible to participate in the study: * Known history of cancer (except squamous cell skin cancer), or coughing up blood in the past 5 years, as reported by the individual * Has undergone a previous lung cancer screening * Inability to speak English * Medical, psychological, or social condition that, in the opinion of the investigator, may increase the patient's risk or limit the patient's adherence with study requirements
Where it's running
-
University of North Carolina-Chapel Hill
Carrboro, North Carolina, United States Recruiting -
Medical University of South Carolina
Charleston, South Carolina, United States Recruiting -
Virginia Commonwealth University
Richmond, Virginia, United States Recruiting
Study contacts
- Principal investigator: Sun Jung Kim, PhD — Virginia Commonwealth University
- Study coordinator: Massey IIT Research Operations
- Email: masseyepd@vcu.edu
- Phone: 804-628-6430
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients
This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.
-
Olive oil before lung cancer surgery to see if it lowers chylothorax
This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.